Petlife Pharmaceuticals IncOver The Counter Market:PTLF
- LAST PRICE0.0001
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close--- / 0.0001
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Petlife Pharmaceuticals Inc | 19.7K | 0.0x | --- |
Nunzia Pharmaceutical Corp | 430.0 | 0.0x | --- |
Neutra Corp | 2.9K | 0.0x | --- |
Lucy Scientific Discovery Inc | 10.6K | 0.0x | --- |
Gelstat Corp | 157.5K | -0.1x | --- |
Earth Life Sciences Inc | 100.0K | -0.2x | --- |
Company Information
PetLife Pharmaceuticals, Inc. is a veterinary pharmaceutical company. The Company specializes in the research, development, sales and support of drugs and nutraceuticals for pet cancer and autoimmune related diseases, such as arthritis. The Company has developed and is launching veterinary cancer medications and nutraceuticals, based on the Escozine formula. The Company has rights to formulate, package and market a product line, Vitalzul. Vitalzul is a polarized, bioactive peptide extracted from the Blue Caribbean Scorpion (Rhopularus Princeps), which contains amino acids, proteins and minerals. Vitalzul inhibits blood vessels formation in solid tumors. Escozine has been used in combination with chemotherapy, radiation, hormone therapy and other conventional treatments. As of August 31, 2016, Escozine (for humans) was sold as either a nutraceutical or prescription drug in 40 countries, including the United States.
Contact Information
- Headquarters
- 8033 W Sunset Blvd Ste 867LOS ANGELES, CA, United States 90046-2401
- Phone
- 424-216-6807
- Fax
- ---
Executives
- Chairman of the Board, President, Chief Executive Officer, Chief Financial Officer, Treasurer, Secretary
- Sebastian Serrell-Watts
- Chief Financial Officer
- Bruce Niswander
- Chief Medical Officer
- Vivek Ramana
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $19.7K |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 196.8M |
Petlife Pharmaceuticals Inc does not pay a dividend. | |
Beta | --- |
EPS | $-0.04 |
Book Value | $-0.02 |
P/E Ratio | 0.0x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
